Revive Selects Pharm-Olam As Contract Research Organization For Infectious Disease Study
This evening, Revive Therapeutics (CSE: RVV) announced that the company has signed with a contract research organization to advance its
Read more
Author: Jay
CME Group To Change Gold Futures Contracts, Increases Margin Requirements
Yesterday, we covered why there was up to a 4% price disparity between the spot price of gold and gold
Read more
Champignon Brands Appoints Dr Joseph Gabriele To Special Advisory Committee
Champignon Brands (CSE: SHRM) this morning announced that it is bolstering its special advisory committee through the appointment of Dr
Read more
Max Resource Enters LOI For Quebec Palladium Project
Max Resource Corp (TSXV: MXR) has entered into a letter of intent through its PGE Americas Metals Corp subsidiary for
Read more
Medipharm Labs Ships First Topical Products
Medipharm Labs (TSX: LABS) is now in the cannabis topicals business. The company announced this morning that it has shipped
Read more
Why Gold Futures Are Not In Line With Spot Prices
It appears that even gold markets are not immune to the effects of a global pandemic, and not in the
Read more
Pandemic Lockdowns Wreak Havoc On Gold Operations Globally
It appears that the mining of gold is slowing globally while the spot price of the metal continues to climb
Read more
Revive Appoints Infectious Disease Expert As Scientific Adviser
Revive Therapeutics (CSE: RVV) this morning announced that they have appointed Dr David Boulware as scientific advisor, aimed at assisting
Read more
Alamos Gold Suspends Operations At Island Gold Mine
Alamos Gold (TSX: AGI) announced this morning that it would be suspending its operations at its Island Gold mine in
Read more
Curaleaf Breaks Trend, Begins Hiring Due To Pandemic Demands
It appears that Curaleaf Holdings (CSE: CURA) has broken the latest trend in the cannabis sector. Rather than looking to
Read more